941 - 950 of 8399 Results
Title
Year
- In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids2023OPENTitle: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloidsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 12Start Page: 2034End Page: 2047Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-023-02080-xBest OA location URL: https://www.nature.com/articles/s41592-023-02080-x.pdfCitation Count: 38
- Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures2023OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adk6191?download=trueCitation Count: 20
- Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease2023OPENTitle: Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: S15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.077212Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.077212Citation Count: 2
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease2023OPENTitle: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 704End Page: 717Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s11481-023-10094-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-023-10094-7.pdfCitation Count: 5
-
OPENTitle: Predicting cognitive decline in a low‐dimensional representation of brain morphologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: S10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.081611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.081611Citation Count: 0
- Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function2023OPENTitle: Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic functionJournal Name: NeuronPublisher: Elsevier BVVol: 111Issue #: 24Start Page: 4006End Page: 4023.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuron.2023.11.020Best OA location URL: http://www.cell.com/article/S0896627323008942/pdfCitation Count: 51
- Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo2023RESTRICTEDTitle: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivoJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 102403End Page: 102403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403Citation Count: 0
- The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski2023OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
- Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection2023OPENTitle: Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selectionJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1293847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1293847/pdf?isPublishedV2=FalseCitation Count: 6
- Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex2023OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15353702231209411Citation Count: 9